Bank of Montreal’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-1
Closed 5118
2019
Q2
$0 Sell
1
-34
-97% -$626 ﹤0.01% 5183
2019
Q1
$1K Sell
35
-36
-51% -$916 ﹤0.01% 4247
2018
Q4
$2K Sell
71
-74
-51% -$2.89K ﹤0.01% 4474
2018
Q3
$8K Buy
145
+70
+93% +$4.47K ﹤0.01% 4014
2018
Q2
$5K Sell
75
-6
-7% -$424 ﹤0.01% 4151
2018
Q1
$5K Buy
81
+22
+37% +$1.93K ﹤0.01% 3927
2017
Q4
$7K Buy
59
+23
+64% +$2.94K ﹤0.01% 3885
2017
Q3
$5K Buy
36
+1
+3% +$134 ﹤0.01% 3877
2017
Q2
$5K Hold
35
﹤0.01% 3882
2017
Q1
$6K Sell
35
-1,199
-97% -$134K ﹤0.01% 3687
2016
Q4
$103K Buy
1,234
+1,124
+1,022% +$88.9K ﹤0.01% 2828
2016
Q3
$8K Buy
110
+75
+214% +$6.01K ﹤0.01% 3614
2016
Q2
$3K Buy
35
+16
+84% +$1.47K ﹤0.01% 3859
2016
Q1
$2K Sell
19
-399
-95% -$39.9K ﹤0.01% 3999
2015
Q4
$84K Sell
418
-11,401
-96% -$2.27M ﹤0.01% 2844
2015
Q3
$1.76M Buy
11,819
+2,989
+34% +$2.19M ﹤0.01% 1352
2015
Q2
$8.38M Sell
8,830
-33
-0.4% -$27K 0.01% 889
2015
Q1
$6.5M Buy
+8,863
New +$6.66M 0.01% 960
2014
Q3
Sell
-18
Closed -$5K 4585
2014
Q2
$5K Buy
+18
New +$3.86K ﹤0.01% 4199
2013
Q3
Sell
-33
Closed -$5K 4002
2013
Q2
$5K Buy
+33
New +$5.23K ﹤0.01% 3458

Other funds holding TTPH

Bank of Montreal's TTPH Position: Q3 2019 in Review

Bank of Montreal sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 1 share.

Bank of Montreal first reported a position in TTPH in Q2 2013 and held it in 20 quarters. The position peaked at $8.38M in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Bank of Montreal reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Bank of Montreal sold 1 Tetraphase Pharmaceuticals, Inc. share in Q3 2019.
  • Bank of Montreal first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Bank of Montreal's Tetraphase Pharmaceuticals, Inc. position peaked at $8.38M in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.